Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Arbitration panel rules in favor of Lilly in complaint filed by Adocia

A Chicago-based arbitration panel ruled in favor of Eli Lilly and Company in a claim filed by Adocia S.A. over the companies’ prior collaboration on a rapid-acting insulin.

Read More »

New Campaign Focuses on Fighting Superbugs

Leading scientists, public policy experts and biotech industry leaders joined forces to launch “Working to Fight AMR,” a coalition working to raise public awareness of the growing threat posed by antimicrobial resistance.

Read More »

Shriners Hospitals for Children Announces New Medical Device for Scoliosis Treatment Approved by FDA

A new medical device for treating scoliosis – curvature of the spine – received FDA approval, providing an alternative that both corrects the curve and maintains flexibility in the spine.

Read More »

Mallinckrodt Announces Positive Top-Line Results from Pivotal Phase 3 Study of Terlipressin in Patients with HRS-1

Mallinckrodt plc announced positive top-line results from the company’s pivotal Phase 3 CONFIRM clinical study evaluating the efficacy and safety of terlipressin in 300 adults with hepatorenal syndrome type 1 (HRS-1).

Read More »

Healthline Hires Vice Presidents of Communications and Consumer Insights

Healthline Media appointed Steve Swasey as vice president of Communications and Laurie Dewan as vice president of Consumer Insights.

Read More »

Jazz Pharmaceuticals Announces Acquisition of Cavion

Jazz Pharmaceuticals plc announced the acquisition of clinical-stage biotechnology company Cavion Inc. through a merger with a Jazz subsidiary.

Read More »

Oncologie, Merck to Collaborate on Gastric Cancer Clinical Trial

Oncologie Inc. announced a clinical collaboration agreement with Merck to evaluate the combination of Oncologie’s investigational drug Bavituximab – an antibody that blocks the activity of phosphatidylserine – and Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) in patients with advanced gastric or gastroesophageal cancer.

Read More »

McCann Health Promotes Hilary Gentile To First Global Chief Strategy Officer

McCann Health announced Hilary Gentile’s promotion to the newly created position of Global Chief Strategy Officer.

Read More »

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-123 Treatment For Acne Vulgaris In Lotion Form

Bausch Health Companies Inc. and the company’s dermatology business Ortho Dermatologics announced that the U.S. Food and Drug Administration accepted the New Drug Application for IDP-123 (tazarotene 0.045%) Lotion, with a PDUFA action date of Dec. 22, 2019.

Read More »

EVERSANA opens offices in Singapore & Mumbai

EVERSANA, a leading independent provider of global commercial services to the life science industry, announced the rapid expansion of the company’s Asia Pacific business with the addition of two new offices in Singapore and Mumbai.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom